Our July research news is live! Read about a Society for Immunotherapy of Cancer honor for Bernard A Fox, two new #TNBC studies, latest interviews with our researchers and clinicians on OncLive.com and CURE Today, and new lab led by Allie Harris Grossmann. More at sway.cloud.microsoft/ggRiZlpfw9NLtz…

🙌🧬It’s official: the first TCR gene therapy for the treatment of cancer received U.S. FDA approval this evening. A milestone event for the oncology community and the 2nd cell therapy approved for solid cancers! Adaptimmune #Tcellpower adaptimmune.com/investors-and-…

Adaptimmune Receives U.S. FDA Accelerated Approval of TECELRA® (afamitresgene autoleucel), the First Approved Engineered Cell Therapy for a Solid Tumor ⁦Providence⁩ ⁦Chiles Research Institute⁩ ⁦Providence Swedish Cancer Institute Research⁩ finance.yahoo.com/news/adaptimmu…

So proud of Ashish Patel, MD, DDS, FACS, master surgeon and Providence Cancer Institute head and neck/microvascular surgery fellowship director. #FinishCancer

Honored to join this morning the indefatigable Becky Roth at KATU News for AM Northwest to discuss cancer research Providence & the “mother of all relays”, #HoodToCoast, which starts this Friday. Thank you Helen Raptis! #FinishCancer Chiles Research Institute katu.com/amnw/am-northw…

Our HPB Surgeons Providence Oregon Dr.'s Jon Gerry and John Creasy raising awareness on HPB diseases on KATU News ! R. Bryan Bell, MD, DDS, FACS, FRCS(Ed) Providence Health AHPBA IHPBA Providence Cancer Institute: Hepatobiliary Cancers and What to Look For katu.com/afternoon-live…

Race time! So excited to be on the #CancerCrushers team at #HoodToCoast24, raising money for cancer research Providence Chiles Research Institute #FinishCancer

R. Bryan Bell, MD, DDS, FACS, FRCS(Ed) and Cancer Crusher Becky Roth stopped by AM Northwest earlier this week. Becky shared her amazing journey to run in #HoodtoCoast and Dr. Bell highlighted the exciting advances in treating #HNC. youtube.com/watch?v=JWqJ6_…

First leg in the books. So inspiring to be in #CancerCrusher Van #2 with this incredible group of cancer survivors and cancer caregivers- each with their own story of courage, grace and passion. #FinishCancer ⁦Providence⁩ ⁦Chiles Research Institute⁩ #HTC24

We're cheering loudly for all the FINISHCANCER Teams participating in #HoodtoCoast this weekend. Click the link to read about our #FINISHCANCER team of Providence caregivers and find out why they participate in this important event. blog.providence.org/cancer/2024-ho…

2nd leg near aptly named Mist, Oregon- team strong and morale high! #HTC24 #FinishCancer Providence Chiles Research Institute

It’s a wrap! The Mother of All Relays, #HTC24, is in the books. I’m grateful for the opportunity to ride and run with this inspiring group of #CancerCrushers- survivors and caregivers alike. Thank you to all who participated & particularly those who fund raised to #FinishCancer.

When I see a hill to climb, I think of patients like Becky Roth. Becky is a 14 year survivor of stage IV oral cancer who underwent extensive surgery, radiation and chemotherapy, as well as reconstruction using BOTH of her fibulas. Nothing compares to her hill. #HTC24

One great example of this is DPV-001 an "off the shelf" cancer vaccine finding success in therapeutic trials via Bernard A Fox Chiles Research Institute onclive.com/view/dr-leidne…

Safe travels to our Bernard A Fox as he heads to Dublin to speak at "Breakthrough Cancer Research" presented by Irish Immunology. The event will feature panel interviews & Q&A w/ immunology leaders. More at @dublingazette dublingazette.com/dublinlocalmat….

Two hugely disappointing trial results announced by ⁦Merck⁩ today: ⁦Phase 3 KEYNOTE-867 (SBRT + pembro in stage 1/2 lung cancer) and KEYNOTE-630 (adjuvant pembro for high risk resected cutaneous SCC) Trials both negative. ⁦ merck.com/news/merck-pro…

We were inspired by the courage, grit, teamwork & tenacity on display last weekend at Hood to Coast. Thank you to all the amazing teams who so far have raised a whopping $950k for #cancerresearch! #TeamShortSqueezeOurInflatedAssets was the top fundraising team, raising $57k+!

Honored to welcome Juan Cubillos-Ruiz ⁦⁦(Juan Cubillos-Ruiz)⁩ as ⁦Chiles Research Institute⁩ visiting professor. Brilliant talk on the role of ER stress in anti-cancer immunity & identifying targets to enhance the efficacy of immunotherapy. ⁦Providence⁩ ⁦Weill Cornell Medicine⁩

Thank you #HoodToCoast and all of the inspiring runners, survivors and fundraisers who came together in support of #cancer research ⁦Providence⁩ ⁦Chiles Research Institute⁩ #HTC24

Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72 Obituary by Bernard A. Fox, James J. Mulé, and Samir N. Khleif. Perlmutter Cancer Center at NYU Langone Health cancerletter.com/obituary/20240…